Year: 2016

UW Spin-Out Seeks to Develop Celiac Disease Therapy

December 20, 2016

SEATTLE and SAN DIEGO, Dec. 20, 2016 – PvP Biologics, a University of Washington spin-out, is advancing a scientifically designed enzyme that could help people with celiac disease. The UW Institute for Protein Design created the enzyme, called KumaMax. It targets parts of gluten that cause the autoimmune reaction leading to celiac disease. The disease…

Read More